AU2001285737A1 - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
AU2001285737A1
AU2001285737A1 AU2001285737A AU8573701A AU2001285737A1 AU 2001285737 A1 AU2001285737 A1 AU 2001285737A1 AU 2001285737 A AU2001285737 A AU 2001285737A AU 8573701 A AU8573701 A AU 8573701A AU 2001285737 A1 AU2001285737 A1 AU 2001285737A1
Authority
AU
Australia
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001285737A
Other languages
English (en)
Inventor
Patrice Guitard
Stefan Hirsch
Freidrich Karl Mayer
Carle Paul
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU2001285737A1 publication Critical patent/AU2001285737A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2001285737A 2000-06-13 2001-06-11 Pharmaceutical compositions Abandoned AU2001285737A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0014448.5A GB0014448D0 (en) 2000-06-13 2000-06-13 Organic compounds
GB0014448 2000-06-13
PCT/EP2001/006596 WO2001095890A2 (fr) 2000-06-13 2001-06-11 Compositions pharmaceutiques

Publications (1)

Publication Number Publication Date
AU2001285737A1 true AU2001285737A1 (en) 2001-12-24

Family

ID=9893569

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001285737A Abandoned AU2001285737A1 (en) 2000-06-13 2001-06-11 Pharmaceutical compositions

Country Status (11)

Country Link
US (1) US20050013858A1 (fr)
EP (1) EP1296646A2 (fr)
JP (1) JP2004503494A (fr)
AU (1) AU2001285737A1 (fr)
CZ (1) CZ20024040A3 (fr)
EE (1) EE200200689A (fr)
GB (1) GB0014448D0 (fr)
HU (1) HUP0301337A3 (fr)
PL (1) PL358275A1 (fr)
SK (1) SK17622002A3 (fr)
WO (1) WO2001095890A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0103046D0 (en) 2001-02-07 2001-03-21 Novartis Ag Organic Compounds
AR034813A1 (es) * 2001-07-20 2004-03-17 Novartis Ag Composiciones farmaceuticas y uso de las mismas

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2673537B1 (fr) * 1991-03-08 1993-06-11 Oreal Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes.
HU219480B (hu) * 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására
IT1261776B (it) * 1993-03-12 1996-06-03 Mendes Srl Uso di terbinafina per il trattamento terapeutico della pneumocistosi.
WO1995016465A1 (fr) * 1993-12-14 1995-06-22 Sandoz Ltd. Compositions pharmaceutiques contenant des carboxylates de polyoxyalkylene d'alkyle
US20020009491A1 (en) * 2000-02-14 2002-01-24 Rothbard Jonathan B. Compositions and methods for enhancing drug delivery across biological membranes and tissues

Also Published As

Publication number Publication date
WO2001095890A2 (fr) 2001-12-20
US20050013858A1 (en) 2005-01-20
GB0014448D0 (en) 2000-08-09
WO2001095890A3 (fr) 2002-05-16
PL358275A1 (en) 2004-08-09
HUP0301337A2 (hu) 2003-08-28
EP1296646A2 (fr) 2003-04-02
HUP0301337A3 (en) 2005-04-28
SK17622002A3 (sk) 2003-05-02
WO2001095890B1 (fr) 2002-07-11
CZ20024040A3 (cs) 2003-04-16
EE200200689A (et) 2004-06-15
JP2004503494A (ja) 2004-02-05

Similar Documents

Publication Publication Date Title
AU781269C (en) Pharmaceutical compositions
AU2001250420A1 (en) Pharmaceutical compositions
AU2001274307A1 (en) Pharmaceutical compositions
AU2002313236A1 (en) Medicinal compositions
AU6219601A (en) Pharmaceutical compositions
GB0009584D0 (en) Pharmaceutical compositions
AU2002302147A1 (en) Pharmaceutical composition
AU3556400A (en) Pharmaceutical compositions
AU2002214324A1 (en) Medicinal compositions
AU8576801A (en) Pharmaceutical compositions
AU2001290239A1 (en) Medicinal composition
AU2001273919A1 (en) Pharmaceutical compositions
AU1390002A (en) Pharmaceutical compositions
AU6460400A (en) Pharmaceutical compositions
GB0009613D0 (en) Pharmaceutical compositions
AU6460200A (en) Pharmaceutical compositions
AU4085201A (en) Pharmaceutical composition
AU6460300A (en) Pharmaceutical compositions
AU6460100A (en) Pharmaceutical compositions
AU3586401A (en) Pharmaceutical composition
AU2001278705A1 (en) Pharmaceutical composition
AU2001282541A1 (en) Medicinal compositions
AU2001285737A1 (en) Pharmaceutical compositions
AUPR529701A0 (en) Pharmaceutical composition
AU2002346223A1 (en) Medicinal compositions